NEURODEGENERATIVE DISEASE, HEREDITARY
Clinical trials for NEURODEGENERATIVE DISEASE, HEREDITARY explained in plain language.
Never miss a new study
Get alerted when new NEURODEGENERATIVE DISEASE, HEREDITARY trials appear
Sign up with your email to follow new studies for NEURODEGENERATIVE DISEASE, HEREDITARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Editing shot aims to halt rare nerve disease in phase 3 trial
Disease control Recruiting nowThis phase 3 trial tests a single dose of NTLA-2001, a gene-editing therapy, in 60 adults with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN), a rare genetic disease that damages nerves. Participants are randomly assigned to receive either the active treatmen…
Matched conditions: NEURODEGENERATIVE DISEASE, HEREDITARY
Phase: PHASE3 • Sponsor: Intellia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Scientists hunt for Parkinson's clues with brain scans
Knowledge-focused Recruiting nowThis study uses advanced brain scans (PET, SPECT, and MRI) to find markers of Parkinson's disease in people with certain genetic mutations. Researchers will look at changes in brain chemicals and structure. The goal is to better understand the disease and help develop new treatme…
Matched conditions: NEURODEGENERATIVE DISEASE, HEREDITARY
Sponsor: University of Exeter • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC